Evolution of the Average Target: Zai Lab Limited

Evolution of the Average Target - Zai Lab Limited

Evolution of the Target Price: Zai Lab Limited

Evolution of the Target Price - Zai Lab Limited

Changes in Analyst Recommendations: Zai Lab Limited

f5d599f637dc7337cc097e783e.-ZHmc2Qu1AUxKV_sL4rMJzOaidCEyQHYRqsdmDjxvYU.nryqOyB4h3dYT26CXuW2U379v6jPv0yMH5xJ1w2I37yR86QrEmLgQFZkMA~8c1f4f5406ed596a1597beb0dfc15cea
11-06 Zai Lab Q3 Performance Meets Expectations With Pivotal 2027 Ahead, UBS Says MT
01-07 UBS Initiates Zai Lab at Buy With $35 Price Target MT
11-05 Zai Lab updates on Amgen's bemarituzumab Phase 1B/3 Fortitude-102 study RE
11-04 Zai Lab Limited Announces Update on Amgen's Bemarituzumab Phase 1B/3 Fortuda-102 Study CI
13/03/25 JPMorgan Adjusts Price Target on Zai Lab to $51 From $44, Keeps Overweight Rating MT
03/03/25 BofA Securities Downgrades Zai Lab to Neutral MT
12/07/24 JPMorgan Cuts Price Target on Zai Lab to $38 From $43, Maintains Overweight Rating MT
14/12/23 Morgan Stanley Starts Coverage on Zai Lab with Overweight Rating, $47.50 Price Target MT
26/10/23 Citigroup Adjusts Price Target on Zai Lab to $128 From $130, Maintains Buy Rating MT
26/10/23 Goldman Sachs Lowers Price Target on Zai Lab to $73.34 From $82.47, Maintains Buy Rating MT
10/08/23 Cantor Fitzgerald Initiates Coverage on Zai Lab With Overweight Rating, $70 Price Target MT
12/06/23 BofA Adjusts Price Target on Zai Lab to $62.50 From $75, Maintains Buy Rating MT
11/05/23 Citigroup Adjusts Price Target on Zai Lab to $130 From $138, Keeps Buy Rating MT
16/03/23 JPMorgan Adjusts Price Target on Zai Lab to $70 From $79, Maintains Overweight Rating MT
18/11/22 JPMorgan Chase Lowers Price Target on Zai Lab to $79 From $96, Maintains Overweight Rating MT
11/11/22 Citigroup Adjusts Price Target on Zai Lab to $127 From $199, Maintains Buy Rating MT
09/08/22 Citigroup Adjusts Zai Lab's Price Target to $199 From $193, Reiterates Buy Rating MT
26/05/22 CSPC Pharma Shares Fall After Weaker 1Q Profit DJ
12/05/22 Citigroup Adjusts Zai Lab Price Target to $193 From $198, Maintains Buy Rating MT
11/05/22 SVB Securities Adjusts Zai Lab Price Target to $95 From $101, Maintains Outperform Rating MT
06/05/22 Guggenheim Adjusts Price Target for Zai Lab to $85 From $134, Maintains Buy Rating MT
21/04/22 SVB Leerink Adjusts Zai Lab Price Target to $101 From $102, Maintains Outperform Rating MT
04/04/22 JPMorgan Lowers Zai Lab's Price Target to $112 From $136, Maintains Overweight Rating MT
03/03/22 Analyst recommendations: Acushnet, Bristol-Myers Squibb, Intel, iQIYI, Polymetal... Zonebourse
02/03/22 SVB Leerink Adjusts Zai Lab Price Target to $102 From $194, Maintains Outperform Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+9.13%
+3.47%
+10.37%
+0.25%
+20.79%
+0.76%
+22.55%
+0.32%
+5.7%
Average +8.15%
Weighted average by Cap. +8.12%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
21.03USD
Average target price
34.21USD
Spread / Average Target
+62.66%
High Price Target
56.00USD
Spread / Highest target
+166.29%
Low Price Target
24.25USD
Spread / Lowest Target
+15.31%

Analyst Consensus Detail

Analyst consensus - Zai Lab Limited

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Zai Lab Limited
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
MarketScreener Ratings - Zai Lab Limited